
NATURE . COM {
}
Title:
Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab | British Journal of Cancer
Description:
Phase III trials of the anti-insulin-like growth factor type 1 receptor (IGF-IR) antibody figitumumab (F) in unselected non-small-cell lung cancer (NSCLC) patients were recently discontinued owing to futility. Here, we investigated a role of free IGF-1 (fIGF-1) as a potential predictive biomarker of clinical benefit from F treatment. Pre-treatment circulating levels of fIGF-1 were tested in 110 advanced NSCLC patients enrolled in a phase II study of paclitaxel and carboplatin given alone (PC) or in combination with F at doses of 10 or 20 mg kg−1 (PCF10, PCF20). Cox proportional hazards model interactions were between 2.5 and 3.5 for fIGF-1 criteria in the 0.5–0.9 ng ml−1 range. Patients above each criterion had a substantial improvement in progression-free survival on PCF20 related to PC alone. Free IGF-1 correlated inversely with IGF binding protein 1 (IGFBP-1, ρ=−0.295, P=0.005), and the pre-treatment ratio of insulin to IGFBP-1 was also predictive of F clinical benefit. In addition, fIGF-1 levels correlated with tumour vimentin expression (ρ=0.594, P=0.021) and inversely with E-cadherin (ρ=–0.389, P=0.152), suggesting a role for fIGF-1 in tumour de-differentiation. Free IGF-1 may contribute to the identification of a subset of NSCLC patients who benefit from F therapy.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Education
- Science
- Health & Fitness
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌆 Monumental Traffic: 20M - 50M visitors per month
Based on our best estimate, this website will receive around 41,362,249 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$521,200 per month
Our calculations suggest that Nature.com earns between $347,485 and $955,583 monthly online from display advertisements.
Keywords {🔍}
patients, igf, figf, levels, cancer, article, growth, pcf, igfbp, google, scholar, insulin, nsclc, benefit, factor, cas, clinical, pfs, insulinlike, ratio, therapy, baseline, pretreatment, tumour, clin, nature, free, predictive, study, figure, gualberto, months, pollak, receptor, lung, bioactivity, data, igfir, binding, high, usa, circulating, treatment, criteria, analysis, identify, figitumumab, ecadherin, total, receiving,
Topics {✒️}
nature portfolio privacy policy research nature middle line represents advertising thermo scientific body mass index social media author information authors 0/ reprints italy assessing her2/neu amplification assessing k-ras mutations drug development full size image author correspondence eml4-alk gene fusion eml4-alk fusion gene open-label open label rabbit anti-pan-cytokeratin small-cell lung cancer pre-treatment circulating levels receiver-operating characteristic total alanine-scanning mutagenesis growth factor-binding proteins kaplan–meier curves plasma concentration–time curve low e-cadherin expression anti-igf-ir therapy high pre-treatment levels f-ihc aqua scores pre-treatment biomarker tests pre-treatment figf-1 levels binding protein-3-selective insulin chemotherapy-naïve stage iiib mouse anti-e-cadherin long-term clinical benefit tumour e-cadherin/vimentin ratio patients received pc significant biomarker/treatment interaction pre-treatment figf-1 criteria permissions small sample size egf receptor family progression-free survival clinical development dolled-filhart mp higher baseline levels
Schema {🗺️}
WebPage:
mainEntity:
headline:Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
description:Phase III trials of the anti-insulin-like growth factor type 1 receptor (IGF-IR) antibody figitumumab (F) in unselected non-small-cell lung cancer (NSCLC) patients were recently discontinued owing to futility. Here, we investigated a role of free IGF-1 (fIGF-1) as a potential predictive biomarker of clinical benefit from F treatment. Pre-treatment circulating levels of fIGF-1 were tested in 110 advanced NSCLC patients enrolled in a phase II study of paclitaxel and carboplatin given alone (PC) or in combination with F at doses of 10 or 20âmgâkgâ1 (PCF10, PCF20). Cox proportional hazards model interactions were between 2.5 and 3.5 for fIGF-1 criteria in the 0.5â0.9ângâmlâ1 range. Patients above each criterion had a substantial improvement in progression-free survival on PCF20 related to PC alone. Free IGF-1 correlated inversely with IGF binding protein 1 (IGFBP-1, Ï=â0.295, P=0.005), and the pre-treatment ratio of insulin to IGFBP-1 was also predictive of F clinical benefit. In addition, fIGF-1 levels correlated with tumour vimentin expression (Ï=0.594, P=0.021) and inversely with E-cadherin (Ï=â0.389, P=0.152), suggesting a role for fIGF-1 in tumour de-differentiation. Free IGF-1 may contribute to the identification of a subset of NSCLC patients who benefit from F therapy.
datePublished:2010-11-23T00:00:00Z
dateModified:2012-03-29T00:00:00Z
pageStart:68
pageEnd:74
sameAs:https://doi.org/10.1038/sj.bjc.6605972
keywords:
Drug therapy
Non-small-cell lung cancer
Predictive markers
IGF-IR
IGF-1
figitumumab
NSCLC
Biomedicine
general
Cancer Research
Epidemiology
Molecular Medicine
Oncology
Drug Resistance
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig5_HTML.jpg
isPartOf:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:104
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:A Gualberto
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:M L Hixon
affiliation:
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
type:Person
name:D D Karp
affiliation:
name:MD Anderson Cancer Center
address:
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:D Li
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
type:Person
name:S Green
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
type:Person
name:M Dolled-Filhart
affiliation:
name:HistoRx Inc.
address:
name:HistoRx Inc., New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:L G Paz-Ares
affiliation:
name:Virgen del Rocio University Hospital
address:
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
type:PostalAddress
type:Organization
type:Person
name:S Novello
affiliation:
name:University of Turin, Orbassano
address:
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
type:PostalAddress
type:Organization
type:Person
name:J Blakely
affiliation:
name:West Clinic
address:
name:Department of Medical Oncology, West Clinic, Memphis, USA
type:PostalAddress
type:Organization
type:Person
name:C J Langer
affiliation:
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:M N Pollak
affiliation:
name:McGill University
address:
name:Department of Medical Oncology, McGill University, Montreal, Canada
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
description:Phase III trials of the anti-insulin-like growth factor type 1 receptor (IGF-IR) antibody figitumumab (F) in unselected non-small-cell lung cancer (NSCLC) patients were recently discontinued owing to futility. Here, we investigated a role of free IGF-1 (fIGF-1) as a potential predictive biomarker of clinical benefit from F treatment. Pre-treatment circulating levels of fIGF-1 were tested in 110 advanced NSCLC patients enrolled in a phase II study of paclitaxel and carboplatin given alone (PC) or in combination with F at doses of 10 or 20âmgâkgâ1 (PCF10, PCF20). Cox proportional hazards model interactions were between 2.5 and 3.5 for fIGF-1 criteria in the 0.5â0.9ângâmlâ1 range. Patients above each criterion had a substantial improvement in progression-free survival on PCF20 related to PC alone. Free IGF-1 correlated inversely with IGF binding protein 1 (IGFBP-1, Ï=â0.295, P=0.005), and the pre-treatment ratio of insulin to IGFBP-1 was also predictive of F clinical benefit. In addition, fIGF-1 levels correlated with tumour vimentin expression (Ï=0.594, P=0.021) and inversely with E-cadherin (Ï=â0.389, P=0.152), suggesting a role for fIGF-1 in tumour de-differentiation. Free IGF-1 may contribute to the identification of a subset of NSCLC patients who benefit from F therapy.
datePublished:2010-11-23T00:00:00Z
dateModified:2012-03-29T00:00:00Z
pageStart:68
pageEnd:74
sameAs:https://doi.org/10.1038/sj.bjc.6605972
keywords:
Drug therapy
Non-small-cell lung cancer
Predictive markers
IGF-IR
IGF-1
figitumumab
NSCLC
Biomedicine
general
Cancer Research
Epidemiology
Molecular Medicine
Oncology
Drug Resistance
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605972/MediaObjects/41416_2011_Article_BF6605972_Fig5_HTML.jpg
isPartOf:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:104
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:A Gualberto
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:M L Hixon
affiliation:
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
type:Person
name:D D Karp
affiliation:
name:MD Anderson Cancer Center
address:
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
type:Person
name:D Li
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
type:Person
name:S Green
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
type:Person
name:M Dolled-Filhart
affiliation:
name:HistoRx Inc.
address:
name:HistoRx Inc., New Haven, USA
type:PostalAddress
type:Organization
type:Person
name:L G Paz-Ares
affiliation:
name:Virgen del Rocio University Hospital
address:
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
type:PostalAddress
type:Organization
type:Person
name:S Novello
affiliation:
name:University of Turin, Orbassano
address:
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
type:PostalAddress
type:Organization
type:Person
name:J Blakely
affiliation:
name:West Clinic
address:
name:Department of Medical Oncology, West Clinic, Memphis, USA
type:PostalAddress
type:Organization
type:Person
name:C J Langer
affiliation:
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
type:Person
name:M N Pollak
affiliation:
name:McGill University
address:
name:Department of Medical Oncology, McGill University, Montreal, Canada
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:British Journal of Cancer
issn:
1532-1827
0007-0920
volumeNumber:104
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
name:MD Anderson Cancer Center
address:
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
type:PostalAddress
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
name:HistoRx Inc.
address:
name:HistoRx Inc., New Haven, USA
type:PostalAddress
name:Virgen del Rocio University Hospital
address:
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
type:PostalAddress
name:University of Turin, Orbassano
address:
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
type:PostalAddress
name:West Clinic
address:
name:Department of Medical Oncology, West Clinic, Memphis, USA
type:PostalAddress
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
name:McGill University
address:
name:Department of Medical Oncology, McGill University, Montreal, Canada
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:A Gualberto
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
email:[email protected]
name:M L Hixon
affiliation:
name:Warren Alpert Medical School at Brown University
address:
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
type:PostalAddress
type:Organization
name:D D Karp
affiliation:
name:MD Anderson Cancer Center
address:
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
type:PostalAddress
type:Organization
name:D Li
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:S Green
affiliation:
name:Pfizer Oncology
address:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
type:PostalAddress
type:Organization
name:M Dolled-Filhart
affiliation:
name:HistoRx Inc.
address:
name:HistoRx Inc., New Haven, USA
type:PostalAddress
type:Organization
name:L G Paz-Ares
affiliation:
name:Virgen del Rocio University Hospital
address:
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
type:PostalAddress
type:Organization
name:S Novello
affiliation:
name:University of Turin, Orbassano
address:
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
type:PostalAddress
type:Organization
name:J Blakely
affiliation:
name:West Clinic
address:
name:Department of Medical Oncology, West Clinic, Memphis, USA
type:PostalAddress
type:Organization
name:C J Langer
affiliation:
name:Abramson Cancer Center, University of Pennsylvania
address:
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
type:PostalAddress
type:Organization
name:M N Pollak
affiliation:
name:McGill University
address:
name:Department of Medical Oncology, McGill University, Montreal, Canada
type:PostalAddress
type:Organization
PostalAddress:
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
name:Department of Pathology and Laboratory Medicine, Warren Alpert Medical School at Brown University, Providence, USA
name:Department of Thoracic Oncology, MD Anderson Cancer Center, Houston, USA
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
name:The Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, USA
name:HistoRx Inc., New Haven, USA
name:Department of Medical Oncology, Virgen del Rocio University Hospital, Seville, Spain
name:Department of Medical Oncology, University of Turin, Orbassano, Turin, Italy
name:Department of Medical Oncology, West Clinic, Memphis, USA
name:Hematology/Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA
name:Department of Medical Oncology, McGill University, Montreal, Canada
External Links {🔗}(103)
- What's the financial intake of https://doi.org/10.1038/bjc.2012.497?
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10404797?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Changes%20in%20free%20insulin-like%20growth%20factor-1%20and%20leptin%20concentrations%20during%20acute%20metabolic%20decompensation%20in%20insulin%20withdrawn%20patients%20with%20type%201%20diabetes&journal=J%20Clin%20Endocrinol%20Metab&volume=84&pages=2324-2328&publication_year=1999&author=Attia%2CN&author=Caprio%2CS&author=Jones%2CTW&author=Heptulla%2CR&author=Holcombe%2CJ&author=Silver%2CD&author=Sherwin%2CRS&author=Tamborlane%2CWV
- How much does https://doi.org/10.1046%2Fj.1365-2265.1996.7760786.x pull in?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Insulin%20treatment%20normalizes%20reduced%20free%20insulin-like%20growth%20factor-I%20concentrations%20in%20diabetic%20children&journal=Clin%20Endocrinol%20%28Oxf%29&doi=10.1046%2Fj.1365-2265.1996.7760786.x&volume=45&pages=321-326&publication_year=1996&author=Bereket%2CA&author=Lang%2CCH&author=Blethen%2CSL&author=Ng%2CLC&author=Wilson%2CTA
- What are the earnings of https://doi.org/10.1258%2F000456307780945778?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=The%20biochemical%20assessment%20of%20insulin%20resistance&journal=Ann%20Clin%20Biochem&doi=10.1258%2F000456307780945778&volume=44&pages=324-342&publication_year=2007&author=Borai%2CA&author=Livingstone%2CC&author=Ferns%2CGA is on a monthly basis
- How much does https://doi.org/10.1210%2Fjc.2007-2454 bring in each month?
- How much income does http://scholar.google.com/scholar_lookup?&title=Normal%20values%20of%20circulating%20insulin-like%20growth%20factor-I%20bioactivity%20in%20the%20healthy%20population%3A%20comparison%20with%20five%20widely%20used%20IGF-1%20immunoassays&journal=J%20Clin%20Endocrinol%20Metab&doi=10.1210%2Fjc.2007-2454&volume=93&pages=2539-2545&publication_year=2008&author=Brugts%2CMP&author=Ranke%2CMB&author=Hofland%2CLJ&author=van%20der%20Wansem%2CK&author=Weber%2CK&author=Frystyk%2CJ&author=Lamberts%2CSW&author=Janssen%2CJA have?
- How much does https://doi.org/10.1210%2Fjc.2007-1633 generate monthly?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Low%20circulating%20insulin-like%20growth%20factor%20I%20bioactivity%20in%20elderly%20men%20is%20associated%20with%20increased%20mortality&journal=J%20Clin%20Endocrinol%20Metab&doi=10.1210%2Fjc.2007-1633&volume=93&pages=2515-2522&publication_year=2008&author=Brugts%2CMP&author=van%20den%20Beld%2CAW&author=Hofland%2CLJ&author=van%20der%20Wansem%2CK&author=van%20Koetsveld%2CPM&author=Frystyk%2CJ&author=Lamberts%2CSW&author=Janssen%2CJA generate?
- How much does https://doi.org/10.2337%2Fdb09-0583 earn?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Igf-I%20bioactivity%20in%20an%20elderly%20population%3A%20relation%20to%20insulin%20sensitivity%2C%20insulin%20levels%2C%20and%20the%20metabolic%20syndrome&journal=Diabetes&doi=10.2337%2Fdb09-0583&volume=59&pages=505-508&publication_year=2010&author=Brugts%2CMP&author=van%20Duijn%2CCM&author=Hofland%2CLJ&author=Witteman%2CJC&author=Lamberts%2CSW&author=Janssen%2CJA
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12473592?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Clinical%20significance%20of%20insulin-like%20growth%20factor-binding%20protein-3%20expression%20in%20stage%20I%20non-small%20cell%20lung%20cancer&journal=Clin%20Cancer%20Res&volume=8&pages=3796-3802&publication_year=2002&author=Chang%2CYS&author=Kong%2CG&author=Sun%2CS&author=Liu%2CD&author=El-Naggar%2CAK&author=Khuri%2CFR&author=Hong%2CWK&author=Lee%2CHY?
- What's the financial gain of https://doi.org/10.1158%2F1078-0432.CCR-07-4879?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=The%20type%201%20insulin-like%20growth%20factor%20receptor%20pathway&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-4879&volume=14&pages=6364-6370&publication_year=2008&author=Chitnis%2CMM&author=Yuen%2CJS&author=Protheroe%2CAS&author=Pollak%2CM&author=Macaulay%2CVM
- How much does https://doi.org/10.1158%2F1078-0432.CCR-04-1070 gross monthly?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Combination%20therapy%20enhances%20the%20inhibition%20of%20tumor%20growth%20with%20the%20fully%20human%20anti-type%201%20insulin-like%20growth%20factor%20receptor%20monoclonal%20antibody%20CP-751%2C871&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-04-1070&volume=11&pages=2063-2073&publication_year=2005&author=Cohen%2CBD&author=Baker%2CDA&author=Soderstrom%2CC&author=Tkalcevic%2CG&author=Rossi%2CAM&author=Miller%2CPE&author=Tengowski%2CMW&author=Wang%2CF&author=Gualberto%2CA&author=Beebe%2CJS&author=Moyer%2CJD generate?
- How much profit does https://doi.org/10.1021%2Fbi990089p make?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Total%20alanine-scanning%20mutagenesis%20of%20insulin-like%20growth%20factor%20I%20%28IGF-1%29%20identifies%20differential%20binding%20epitopes%20for%20IGFBP-1%20and%20IGFBP-3&journal=Biochemistry&doi=10.1021%2Fbi990089p&volume=38&pages=6386-6396&publication_year=1999&author=Dubaqui%C3%A9%2CY&author=Lowman%2CHB generate?
- How much does https://doi.org/10.1210%2Fendo.142.1.7864 make?
- How much does http://scholar.google.com/scholar_lookup?&title=Binding%20protein-3-selective%20insulin-like%20growth%20factor%20I%20variants%3A%20engineering%2C%20biodistributions%2C%20and%20clearance&journal=Endocrinology&doi=10.1210%2Fendo.142.1.7864&volume=142&pages=165-173&publication_year=2001&author=Dubaqui%C3%A9%2CY&author=Mortensen%2CDL&author=Intintoli%2CA&author=Hogue%2CDA&author=Nakamura%2CG&author=Rancatore%2CP&author=Lester%2CP&author=Sadick%2CMD&author=Filvaroff%2CE&author=Fielder%2CPJ&author=Lowman%2CHB net monthly?
- How profitable is https://doi.org/10.1002%2Fijc.2910560618?
- http://scholar.google.com/scholar_lookup?&title=Expression%20and%20function%20of%20the%20insulin%20like%20growth%20factor%201%20system%20in%20human%20non%20small%20cell%20lung%20cancer%20and%20normal%20lung%20cell%20lines&journal=Int%20J%20Cancer&doi=10.1002%2Fijc.2910560618&volume=56&pages=858-866&publication_year=1994&author=Favoni%2CRE&author=de%20Cupis%2CA&author=Ravera%2CF&author=Cantoni%2CC&author=Pirani%2CP&author=Ardizzoni%2CA&author=Noonan%2CD&author=Biassoni%2CR income
- How much income does https://link.springer.com/doi/10.1007/s11102-007-0025-y have?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Utility%20of%20free%20IGF-1%20measurements&journal=Pituitary&doi=10.1007%2Fs11102-007-0025-y&volume=10&pages=181-187&publication_year=2007&author=Frystyk%2CJ
- What's the financial outcome of https://doi.org/10.1517%2F14712591003689980?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Figitumumab%20%28CP-751%2C871%29%20for%20cancer%20therapy&journal=Expert%20Opin%20Biol%20Ther&doi=10.1517%2F14712591003689980&volume=10&pages=575-585&publication_year=2010&author=Gualberto%2CA
- How much does https://doi.org/10.1200%2FJCO.2008.21.7695 pull in monthly?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Molecular%20basis%20for%20sensitivity%20to%20figitumumab%20%28CP-751%2C871%29%20in%20NSCLC&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2008.21.7695&volume=27&publication_year=2009&author=Gualberto%2CA&author=Dolled-Filhart%2CMP&author=Hixon%2CML&author=Christensen%2CJ&author=Rimm%2CDL&author=Lee%2CAV&author=Wang%2CY&author=Pollak%2CM&author=Paz-Ares%2CLG&author=Karp%2CDD?
- How much does https://doi.org/10.1038%2Fonc.2009.172 generate monthly?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Emerging%20role%20of%20insulin-like%20growth%20factor%20receptor%20inhibitors%20in%20oncology%3A%20early%20clinical%20trial%20results%20and%20future%20directions&journal=Oncogene&doi=10.1038%2Fonc.2009.172&volume=28&pages=3009-3021&publication_year=2009&author=Gualberto%2CA&author=Pollak%2CM?
- What's the financial outcome of https://doi.org/10.1016%2Fj.lungcan.2006.07.014?
- Revenue of http://scholar.google.com/scholar_lookup?&title=The%20prognostic%20significance%20of%20pretreatment%20plasma%20levels%20of%20insulin-like%20growth%20factor%20%28IGF%29-1%2C%20IGF-2%2C%20and%20IGF%20binding%20protein-3%20in%20patients%20with%20advanced%20non-small%20cell%20lung%20cancer&journal=Lung%20Cancer&doi=10.1016%2Fj.lungcan.2006.07.014&volume=54&pages=227-234&publication_year=2006&author=Han%2CJY&author=Choi%2CBG&author=Choi%2CJY&author=Lee%2CSY&author=Ju%2CSY
- What's https://doi.org/10.1161%2F01.ATV.18.2.277's gross income?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Serum%20total%20IGF-1%2C%20free%20IGF-1%2C%20and%20IGFB-1%20levels%20in%20an%20elderly%20population%3A%20relation%20to%20cardiovascular%20risk%20factors%20and%20disease&journal=Arterioscler%20Thromb%20Vasc%20Biol&doi=10.1161%2F01.ATV.18.2.277&volume=18&pages=277-282&publication_year=1998&author=Janssen%2CJA&author=Stolk%2CRP&author=Pols%2CHA&author=Grobbee%2CDE&author=Lamberts%2CSW?
- Check the income stats for https://doi.org/10.1200%2Fjco.2010.28.15_suppl.7500
- How much money does http://scholar.google.com/scholar_lookup?&title=Randomized%2C%20open%20label%2C%20phase%20III%20trial%20of%20figitumumab%20in%20combination%20with%20paclitaxel%20and%20carboplatin%20versus%20paclitaxel%20and%20carboplatin%20in%20patients%20with%20non-small%20cell%20lung%20cancer%20%28NSCLC%29&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2010.28.15_suppl.7500&volume=28&publication_year=2010&author=Jassem%2CJ&author=Langer%2CCJ&author=Karp%2CDD&author=Mok%2CT&author=Benner%2CRJ&author=Green%2CSJ&author=Park%2CK&author=Novello%2CS&author=Strausz%2CJ&author=Gualberto%2CA make?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20insulin-like%20growth%20factors%20in%20the%20epithelial%20to%20mesenchymal%20transition&publication_year=2005&author=Julien-Grille%2CS&author=Moore%2CR&author=Denat%2CL&author=Morali%2COG&author=Delmas%2CV&author=Bellacosa%2CA&author=Laure%2CL generate?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9253324?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Free%20insulin-like%20growth%20factor%20I%20serum%20levels%20in%201430%20healthy%20children%20and%20adults%2C%20and%20its%20diagnostic%20value%20in%20patients%20suspected%20of%20growth%20hormone%20deficiency&journal=J%20Clin%20Endocrinol%20Metab&volume=82&pages=2497-2502&publication_year=1997&author=Juul%2CA&author=Holm%2CK&author=Kastrup%2CKW&author=Pedersen%2CSA&author=Michaelsen%2CKF&author=Scheike%2CT&author=Rasmussen%2CS&author=M%C3%BCller%2CJ&author=Skakkebaek%2CNE
- Learn how profitable https://doi.org/10.1172%2FJCI39104 is on a monthly basis
- http://scholar.google.com/scholar_lookup?&title=The%20basics%20of%20epithelial%E2%80%93mesenchymal%20transition&journal=J%20Clin%20Invest&doi=10.1172%2FJCI39104&volume=119&pages=1420-1428&publication_year=2009&author=Kalluri%2CR&author=Weinberg%2CRA's revenue stream
- Explore the financials of https://doi.org/10.1200%2FJCO.2008.19.9331
- How much does http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20the%20anti-insulin-like%20growth%20factor%20type%201%20receptor%20antibody%20CP-751%2C871%20in%20combination%20with%20paclitaxel%20and%20carboplatin%20in%20previously%20untreated%2C%20locally%20advanced%2C%20or%20metastatic%20non-small-cell%20lung%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2008.19.9331&volume=27&pages=2516-2522&publication_year=2009&author=Karp%2CDD&author=Paz-Ares%2CLG&author=Novello%2CS&author=Haluska%2CP&author=Garland%2CL&author=Cardenal%2CF&author=Blakely%2CLJ&author=Eisenberg%2CPD&author=Langer%2CCJ&author=Blumenschein%2CG&author=Johnson%2CFM&author=Green%2CS&author=Gualberto%2CA net monthly?
- What's the total monthly financial gain of https://doi.org/10.1016%2F1357-2725%2896%2900005-2?
- How much does http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor-binding%20proteins%20%28IGFBPs%29%20and%20their%20regulatory%20dynamics&journal=Int%20J%20Biochem%20Cell%20Biol&doi=10.1016%2F1357-2725%2896%2900005-2&volume=28&pages=619-637&publication_year=1996&author=Kelley%2CKM&author=Oh%2CY&author=Gargosky%2CSE&author=Gucev%2CZ&author=Matsumoto%2CT&author=Hwa%2CV&author=Ng%2CL&author=Simpson%2CDM&author=Rosenfeld%2CRG earn?
- Financial intake of https://doi.org/10.1158%2F1078-0432.CCR-08-0168
- Earnings of http://scholar.google.com/scholar_lookup?&title=EML4-ALK%20fusion%20gene%20and%20efficacy%20of%20an%20ALK%20kinase%20inhibitor%20in%20lung%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-08-0168&volume=14&pages=4275-4283&publication_year=2008&author=Koivunen%2CJP&author=Mermel%2CC&author=Zejnullahu%2CK&author=Murphy%2CC&author=Lifshits%2CE&author=Holmes%2CAJ&author=Choi%2CHG&author=Kim%2CJ&author=Chiang%2CD&author=Thomas%2CR&author=Lee%2CJ&author=Richards%2CWG&author=Sugarbaker%2CDJ&author=Ducko%2CC&author=Lindeman%2CN&author=Marcoux%2CJP&author=Engelman%2CJA&author=Gray%2CNS&author=Lee%2CC&author=Meyerson%2CM&author=J%C3%A4nne%2CPA
- Profit of https://doi.org/10.3181%2F00379727-204-43630
- How much profit does http://scholar.google.com/scholar_lookup?&title=Regulation%20and%20function%20of%20insulin-like%20growth%20factor%20binding%20protein-1&journal=Proc%20Soc%20Exp%20Biol%20Med&doi=10.3181%2F00379727-204-43630&volume=204&pages=4-29&publication_year=1993&author=Lee%2CPD&author=Conover%2CCA&author=Powell%2CDR make?
- What's the financial outcome of https://doi.org/10.1038%2Fsj.onc.1204660?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=IGF-2%20induces%20rapid%20beta-catenin%20relocation%20to%20the%20nucleus%20during%20epithelium%20to%20mesenchyme%20transition&journal=Oncogene&doi=10.1038%2Fsj.onc.1204660&volume=20&pages=4942-4950&publication_year=2001&author=Morali%2COG&author=Delmas%2CV&author=Moore%2CR&author=Jeanney%2CC&author=Thiery%2CJP&author=Larue%2CL?
- How much does https://doi.org/10.2337%2Fdiabetes.50.1.32 earn?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Physiological%20differences%20in%20insulin-like%20growth%20factor%20binding%20protein-1%20%28IGFBP-1%29%20phosphorylation%20in%20IGFBP-1%20transgenic%20mice&journal=Diabetes&doi=10.2337%2Fdiabetes.50.1.32&volume=50&pages=32-38&publication_year=2001&author=Sakai%2CK&author=D%E2%80%99Ercole%2CAJ&author=Murphy%2CLJ&author=Clemmons%2CDR
- What's the revenue for https://doi.org/10.1073%2Fpnas.210394297?
- http://scholar.google.com/scholar_lookup?&title=Insulin-like%20growth%20factor%201%20regulates%20the%20location%2C%20stability%2C%20and%20transcriptional%20activity%20of%20beta-catenin&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.210394297&volume=9&pages=12103-12108&publication_year=2000&author=Playford%2CMP&author=Bicknell%2CD&author=Bodmer%2CWF&author=Macaulay%2CVM income
- What is the earnings of https://doi.org/10.1038%2Fnrc2536?
- How much income is http://scholar.google.com/scholar_lookup?&title=Insulin%20and%20insulin-like%20growth%20factor%20signalling%20in%20neoplasia&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2536&volume=8&pages=915-928&publication_year=2008&author=Pollak%2CM earning monthly?
- How much does https://doi.org/10.1093%2Fjnci%2Fdjp280 generate monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Biomarkers%20predicting%20clinical%20outcome%20of%20epidermal%20growth%20factor%20receptor-targeted%20therapy%20in%20metastatic%20colorectal%20cancer&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdjp280&volume=101&pages=1308-1324&publication_year=2009&author=Siena%2CS&author=Sartore-Bianchi%2CA&author=Di%20Nicolantonio%2CF&author=Balfour%2CJ&author=Bardelli%2CA gross monthly?
- What's the income of https://doi.org/10.1200%2FJCO.2007.14.8197?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Guidelines%20for%20human%20epidermal%20growth%20factor%20receptor%202%20testing%3A%20biologic%20and%20methodologic%20considerations&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2007.14.8197&volume=27&pages=1323-1333&publication_year=2009&author=Sauter%2CG&author=Lee%2CJ&author=Bartlett%2CJM&author=Slamon%2CDJ&author=Press%2CMF?
- Discover the revenue of https://doi.org/10.1200%2FJCO.2009.26.3996
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Epidermal%20growth%20factor%20receptor%20biomarkers%20in%20non-small-cell%20lung%20cancer%3A%20a%20riddle%2C%20wrapped%20in%20a%20mystery%2C%20inside%20an%20enigma&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2009.26.3996&volume=28&pages=903-905&publication_year=2010&author=Shepherd%2CFA&author=Tsao%2CMS
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12433720?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Serum%20insulin%20like%20growth%20factor%20%28IGF%29%20and%20IGF%20binding%20protein%20levels%20and%20risk%20of%20lung%20cancer%3A%20a%20case%20control%20study%20nested%20in%20the%20beta%20carotene%20and%20retinol%20efficacy%20trial%20cohort&journal=Cancer%20Epidemiol%20Biomarkers%20Prev&volume=11&pages=1413-1418&publication_year=2002&author=Spitz%2CMR&author=Barnett%2CMJ&author=Goodman%2CGE&author=Thornquist%2CMD&author=Wu%2CX&author=Pollak%2CM generate?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Receiver-operating%20characteristic%20%28ROC%29%20plots%3A%20a%20fundamental%20evaluation%20tool%20in%20clinical%20medicine&journal=Clin%20Chem&volume=39&pages=561-577&publication_year=1993&author=Zweig%2CMH&author=Campbell%2CG?
- https://citation-needed.springer.com/v2/references/10.1038/sj.bjc.6605972?format=refman&flavour=references's financial summary
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A%20Gualberto produce monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A%20Gualberto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20L%20Hixon?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20L%20Hixon%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D%20D%20Karp
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D%20D%20Karp%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=D%20Li pull in monthly?
- Financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22D%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Find out how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20Green earns monthly
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20Green%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20Dolled-Filhart have?
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20Dolled-Filhart%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=L%20G%20Paz-Ares?
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22L%20G%20Paz-Ares%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=S%20Novello generate?
- Discover the revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22S%20Novello%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J%20Blakely make?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J%20Blakely%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C%20J%20Langer making per month?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C%20J%20Langer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=M%20N%20Pollak generate monthly?
- What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22M%20N%20Pollak%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much revenue does https://s100.copyright.com/AppDispatchServlet?title=Pre-treatment%20levels%20of%20circulating%20free%20IGF-1%20identify%20NSCLC%20patients%20who%20derive%20clinical%20benefit%20from%20figitumumab&author=A%20Gualberto%20et%20al&contentID=10.1038%2Fsj.bjc.6605972©right=The%20Author%28s%29&publication=0007-0920&publicationDate=2010-11-23&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY-NC-SA bring in?
- Monthly income for https://citation-needed.springer.com/v2/references/10.1038/sj.bjc.6605972?format=refman&flavour=citation
- Monthly income for https://doi.org/10.1186/s13045-018-0616-2
- How much does https://doi.org/10.1038/nrc3215 bring in each month?
- https://doi.org/10.1007/s10911-012-9268-y income
- How much revenue does https://doi.org/10.1038/bjc.2011.412 generate?
- How much income is https://doi.org/10.1038/bjc.2011.413 earning monthly?
- Financial intake of https://www.protocols.io/
- How much does https://www.natureindex.com/ net monthly?
- Revenue of http://www.naturechina.com
- How much income does https://www.natureasia.com/ja-jp have?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref